Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
2,035,990
-
Shares change
-
-522,161
-
Total reported value, excl. options
-
$431,583
-
Value change
-
-$638,844
-
Put/Call ratio
-
6.8%
-
Number of buys
-
14
-
Number of sells
-
17
-
Price
-
$0.2140
Institutional Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q4 2024
As of 31 Dec 2024 BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) had 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,035,990 shares of stock of the company.
Largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, Values First Advisors, Inc., Atria Wealth Solutions, Inc., LPL Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, Orin Green Financial, LLC, RHUMBLINE ADVISERS, and Gradient Investments LLC.
This table shows 44 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.